Skip to content
Tablet (Delayed Release) Allopathic

Posanox 100 mg tablet (delayed release)

Generic: Posaconazole

Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength100 mg
PackBox of 10: 2000.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per tablet (delayed release). Ask your pharmacist before you switch brands.

Posaconazole 100 mg tablet (delayed release)s

Prices as listed on BestinMeds.

2 brands listed
Posanox, box of 10 (this medicine)200.00 taka per tablet (delayed release)
Xpos, box of 10200.00 taka per tablet (delayed release)

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Posaconazole guide

Indications

Invasive aspergillosis Posaconazole is indicated in patients aged 13 years and above for the treatment of the following fungal infections: Invasive aspergillosis in patients with disease that is refractory or intolerant to Amphotericin B or Itraconazole Fusariosis in patients with disease that is refractory or intolerant to Amphotericin B ... Read more Posaconazole is indicated in patients aged 13 years and above for the treatment of the following fungal infections: Invasive aspergillosis in patients with disease that is refractory or intolerant to Amphotericin B or Itraconazole Fusariosis in patients with disease that is refractory or intolerant to Amphotericin B Chromoblastomycosis and mycetoma in patients with disease that is refractory or intolerant to Itraconazole Coccidioidomycosis in patients with disease that is refractory or intolerant to Amphotericin B, Itraconazole or Fluconazole or in patients who are intolerant of these medicinal products. Also indicated for prophylaxis of invasive fungal infections in the following patients: Patients receiving remission-induction chemotherapy for Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndromes (MDS) expected to result in prolonged neutropenia and who are at high risk of developing invasive fungal infections Hematopoietic Stem Cell Transplant (HSCT) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy

Dosage and administration

Posaconazole Tablets can be taken with or without food. The tablets should be swallowed whole with water and should not be crushed, chewed, or broken. Loading Dose: 300 mg (3 Tablets) twice a day on the first day. Maintenance Dose: 300 mg (3 Tablets) once a day from the second day. Duration of therapy should be based on the severity of the underlying disease, recovery from immunosuppression and clinical response.

Side effects

Common treatment-emergent adverse reactions in studies with Posaconazole are diarrhea, nausea, fever, vomiting, headache, coughing and hypokalemia.

Precautions and warnings

This information is not available. Ask your doctor or pharmacist.

Pregnancy and lactation

Posaconazole must not be used during pregnancy unless the benefit to the mother clearly outweighs the potential risk to the fetus. Breast-feeding must be stopped on initiation of treatment with this drug.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250